INTRODUCTION
From the end of 2019, a viral infection caused by a new coronavirus has emerged in Wuhan, China, and by March 11, 2020, the world health organization declared this viral disease, now recognized as SARS-CoV-2, as a pandemic disease.1–3
In the few months that this infection has been observed, there has been a fast and continuous knowledge contribution on epidemiology, genetics, virology, diagnosis, and especially on the clinical aspect, highlighting knowledge of lung disease. 4,5
During pregnancy, in theory, the risk of adverse outcomes for the mother and her child increases if she contracts a viral respiratory infection. Even maternal morbidity and lethality increases when compared to nonpregnant women. 6–9 In fact, this association has been observed in mothers infected with other coronaviruses (SARS-CoV and MERS-Cov). 6,9 Adverse perinatal outcomes such as prematurity, intrauterine death, and postnatal death have also been reported with other coronavirus infections. 10,11
With the increasing number of cases worldwide, and countries reporting more and more cases, it is obvious that there will be an increasing number of pregnant women infected with SARS-CoV-2. 12
There are currently a variety of publications around SARS-CoV-2, ranging from one case to a series of 16 cases. 13–15 Most of these publications report good maternal and neonatal evolution, unlike reports in pregnant women with other coronavirus infections.6–11
The objective of this study is to show the medical and clinical findings of pregnant women infected with SARS-CoV-2, and also the evolution of the newborn, based on publications made available until March 30, 2020, so that the physician can prepare for management and counseling of pregnant women who may be diagnosed with SAR-CoV-2 infection.